iRhythm Technologies (NASDAQ:IRTC – Get Free Report)’s share price traded up 6.9% during mid-day trading on Wednesday. The company traded as high as $96.81 and last traded at $95.8520. Approximately 107,043 shares were traded during trading, a decline of 83% from the average daily volume of 630,315 shares. The stock had previously closed at $89.67.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on IRTC shares. Needham & Company LLC reduced their price objective on shares of iRhythm Technologies from $194.00 to $165.00 and set a “buy” rating for the company in a research report on Friday, November 6th. Truist Financial cut their target price on iRhythm Technologies from $168.00 to $140.00 and set a “buy” rating for the company in a research note on Monday, November 9th. Wall Street Zen downgraded iRhythm Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, October 10th. BTIG Research dropped their price objective on iRhythm Technologies from $185.00 to $170.00 and set a “buy” rating on the stock in a report on Friday, November 6th. Finally, Piper Sandler reduced their target price on iRhythm Technologies from $160.00 to $150.00 and set an “overweight” rating for the company in a report on Friday, November 6th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $164.07.
Check Out Our Latest Research Report on iRhythm Technologies
iRhythm Technologies Stock Performance
iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.80. The business had revenue of $221.59 million during the quarter, compared to the consensus estimate of $222.23 million. iRhythm Technologies had a positive return on equity of 26.88% and a negative net margin of 4.52%. The business’s revenue was up 14.9% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.06) EPS. As a group, sell-side analysts anticipate that iRhythm Technologies will post 0.79 EPS for the current year.
iRhythm Technologies announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, November 11th that allows the company to buy back $200 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.7% of its shares through open market purchases. Share repurchase plans are usually a sign that the company’s management believes its stock is undervalued.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of IRTC. Stephens Investment Management Group LLC boosted its holdings in shares of iRhythm Technologies by 1.7% during the third quarter. Stephens Investment Management Group LLC now owns 705,533 shares of the company’s stock worth $80,191,000 after purchasing an additional 12,096 shares during the last quarter. Braidwell LP increased its stake in iRhythm Technologies by 7.2% in the second quarter. Braidwell LP now owns 654,262 shares of the company’s stock valued at $77,824,000 after purchasing an additional 44,070 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in iRhythm Technologies by 99.2% during the first quarter. The Manufacturers Life Insurance Company now owns 390,577 shares of the company’s stock worth $46,096,000 after buying an additional 194,502 shares during the period. Rock Springs Capital Management LP boosted its stake in iRhythm Technologies by 11.4% in the 1st quarter. Rock Springs Capital Management LP now owns 261,750 shares of the company’s stock worth $30,892,000 after buying an additional 26,750 shares during the last quarter. Finally, Voya Investment Management LLC grew its holdings in iRhythm Technologies by 3,578.5% in the 3rd quarter. Voya Investment Management LLC now owns 230,934 shares of the company’s stock valued at $26,248,000 after buying an additional 224,656 shares during the period.
iRhythm Technologies Company Profile
iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.
Read More
- Five stocks we like better than iRhythm Technologies
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
